Flare Phenomenon in O-(2-18F-Fluoroethyl)-l-Tyrosine PET After Resection of Gliomas. 2020

Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
Institute of Neuroscience and Medicine (INM-3, INM-4, and INM-5), Forschungszentrum Jülich, Jülich, Germany.

PET using O-(2-18F-fluoroethyl)-l-tyrosine (18F-FET) is useful to detect residual tumor tissue after glioma resection. Recent animal experiments detected reactive changes in 18F-FET uptake at the rim of the resection cavity within the first 2 wk after resection of gliomas. In the present study, we evaluated pre- and postoperative 18F-FET PET scans of glioma patients with particular emphasis on the identification of reactive changes after surgery. Methods: Forty-three patients with cerebral gliomas (9 low-grade, 34 high-grade; 9 primary tumors, 34 recurrent tumors) who had preoperative (time before surgery: median, 23 d; range, 6-44 d) and postoperative 18F-FET PET (time after surgery: median, 14 d; range, 5-28 d) were included. PET scans (20-40 min after injection) were evaluated visually for complete or incomplete resection and compared with MRI. Changes in 18F-FET uptake were evaluated by tumor-to-brain ratios in residual tumor and by maximum lesion-to-brain ratios near the resection cavity. Results: Visual analysis of 18F-FET PET scans revealed complete resection in 16 of 43 patients and incomplete resection in the remaining patients. PET results were concordant with MRI in 69% of the patients. The maximum lesion-to-brain ratio for 18F-FET uptake near the resection cavity was significantly higher than preoperative values (1.59 ± 0.36 vs. 1.14 ± 0.17; n = 43; P < 0.001). In 11 patients (26%), a flare phenomenon was observed, with a considerable increase in 18F-FET uptake compared with preoperative values in either the residual tumor (n = 5) or areas remote from the tumor on the preoperative PET scan (n = 6) (2.92 ± 1.24 vs. 1.62 ± 0.75; P < 0.001). Further follow-up in 5 patients showed decreasing 18F-FET uptake in the flare areas in 4 patients and progress in 1 patient. Conclusion: Our study confirmed that 18F-FET PET provides valuable information for assessing the success of glioma resection. Postoperative reactive changes at the rim of the resection cavity appear to be mild. However, in 23% of the patients, a postoperative flare phenomenon was observed that warrants further investigation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005260 Female Females
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014443 Tyrosine A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. L-Tyrosine,Tyrosine, L-isomer,para-Tyrosine,L Tyrosine,Tyrosine, L isomer,para Tyrosine
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission

Related Publications

Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
December 2020, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
December 2020, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
August 2017, EJNMMI research,
Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
September 2014, Journal of nuclear medicine technology,
Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
March 2005, Brain : a journal of neurology,
Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
November 2020, Acta oncologica (Stockholm, Sweden),
Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
June 2020, European journal of nuclear medicine and molecular imaging,
Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
March 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
May 2016, Clinical cancer research : an official journal of the American Association for Cancer Research,
Christian P Filss, and Ann K Schmitz, and Gabriele Stoffels, and Carina Stegmayr, and Philipp Lohmann, and Jan Michael Werner, and Michael Sabel, and Marion Rapp, and Roland Goldbrunner, and Bernd Neumaier, and Felix M Mottaghy, and N Jon Shah, and Gereon R Fink, and Norbert Galldiks, and Karl-Josef Langen
April 2015, European journal of nuclear medicine and molecular imaging,
Copied contents to your clipboard!